Subscribe
shutterstock_2034751574_rudy_balasko
Rudy Balasko / Shutterstock.com
27 June 2023Big PharmaMarisa Woutersen

UPC: Milan confirmed as third seat but Munich lands chemistry, minus SEPs

UPC Administrative Committee 'voted unanimously' to approve Milan | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs | 23 cases currently before the court.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Munich court rules for Bio-Rad in 10x Genomics dispute
3 December 2019   California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.
Big Pharma
Reddie & Grose adds new partner in Munich
2 July 2019   Reddie & Grose has appointed Robin Ellis as a partner in the firm’s Munich office.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Big Pharma
Reddie & Grose adds new partner in Munich
2 July 2019   Reddie & Grose has appointed Robin Ellis as a partner in the firm’s Munich office.
Americas
Munich court rules for Bio-Rad in 10x Genomics dispute
3 December 2019   California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.

More on this story

Big Pharma
Reddie & Grose adds new partner in Munich
2 July 2019   Reddie & Grose has appointed Robin Ellis as a partner in the firm’s Munich office.
Americas
Munich court rules for Bio-Rad in 10x Genomics dispute
3 December 2019   California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages